• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Plasma homocysteine levels and mortality in patients with coronary artery disease.

作者信息

von Eckardstein A, Assmann G

出版信息

N Engl J Med. 1997 Nov 27;337(22):1632-3.

PMID:9411228
Abstract
摘要

相似文献

1
Plasma homocysteine levels and mortality in patients with coronary artery disease.冠心病患者的血浆同型半胱氨酸水平与死亡率
N Engl J Med. 1997 Nov 27;337(22):1632-3.
2
[Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease].[血浆同型半胱氨酸独立于传统危险因素及C反应蛋白，可预测血管造影确诊的冠心病患者的死亡率]
Ital Heart J Suppl. 2001 Jan;2(1):81-2.
3
Plasma homocysteine levels and mortality in patients with coronary artery disease.冠心病患者的血浆同型半胱氨酸水平与死亡率
N Engl J Med. 1997 Nov 27;337(22):1632; author reply 1632-3.
4
[Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].[冠状动脉搭桥术后血浆同型半胱氨酸水平升高与大隐静脉移植血管病变的关系]
J Cardiol. 1998 Dec;32(6):357-62.
5
Plasma homocysteine levels and mortality in patients with coronary artery disease.冠状动脉疾病患者的血浆同型半胱氨酸水平与死亡率
N Engl J Med. 1997 Nov 27;337(22):1631-2; author reply 1632-3. doi: 10.1056/NEJM199711273372215.
6
Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.血浆同型半胱氨酸水平与冠状动脉疾病之间的关联：希腊北部一项基于人群的研究。
Curr Med Res Opin. 2004;20(2):175-80. doi: 10.1185/030079903125002856.
7
Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.同型半胱氨酸：成人冠状动脉疾病及其他动脉闭塞性疾病的一个独立危险因素。
Prog Cardiovasc Nurs. 1995 Fall;10(4):37-8.
8
Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?急性冠状动脉综合征中同型半胱氨酸水平的早期测定，它是一个独立的预后因素吗？
Int J Cardiol. 2005 Apr 20;100(2):275-9. doi: 10.1016/j.ijcard.2004.09.001.
9
[Plasma homocysteine levels in Spanish patients with coronary artery disease].[西班牙冠状动脉疾病患者的血浆同型半胱氨酸水平]
An Med Interna. 2002 Apr;19(4):166-70.
10
Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.泰国冠状动脉疾病患者血清同型半胱氨酸、维生素B12、叶酸之间的关联。
J Med Assoc Thai. 2000 May;83(5):536-42.

引用本文的文献

1
Homocysteine Plasmatic Concentration in Brain-Injured Neurocritical Care Patients: Systematic Review of Clinical Evidence.脑损伤神经重症监护患者的血浆同型半胱氨酸浓度：临床证据的系统评价
J Clin Med. 2022 Jan 13;11(2):394. doi: 10.3390/jcm11020394.
2
Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies.高同型半胱氨酸血症作为某些病症的危险因素和潜在的营养保健品作用靶点。
Front Nutr. 2019 Apr 24;6:49. doi: 10.3389/fnut.2019.00049. eCollection 2019.
3
A20 alleviates the vascular remodeling induced by homocysteine.
A20可减轻同型半胱氨酸诱导的血管重塑。
Am J Transl Res. 2018 Dec 15;10(12):3991-4003. eCollection 2018.
4
Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach.采用 UHPLC-QTOF/MS 代谢组学方法研究冠心病发病机制中潜在的新型代谢物。
Sci Rep. 2017 Nov 10;7(1):15357. doi: 10.1038/s41598-017-15737-3.
5
The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.叶酸强化对基于叶酸的降低同型半胱氨酸干预及中风风险的影响：一项荟萃分析。
Public Health Nutr. 2015 Jun;18(8):1514-21. doi: 10.1017/S1368980014002134. Epub 2014 Oct 17.
6
Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases.2型糖尿病患者血浆同型半胱氨酸水平升高：心血管疾病的一个危险因素。
Pan Afr Med J. 2012;12:48. Epub 2012 Jun 24.
7
Relationship of carotid intima-media thickness and duration of vegetarian diet in Chinese male vegetarians.中国男性素食者颈动脉内膜中层厚度与素食时间的关系。
Nutr Metab (Lond). 2011 Sep 19;8(1):63. doi: 10.1186/1743-7075-8-63.